Teva Pharmaceutical Industries Other Operating Income or Expenses 2010-2024 | TEVA

Teva Pharmaceutical Industries annual/quarterly other operating income or expenses history and growth rate from 2010 to 2024. Other operating income or expenses can be defined as the aggregate amount of all operating expenses either too small to report separately or that cannot be standardized into another Zacks field.
  • Teva Pharmaceutical Industries other operating income or expenses for the quarter ending September 30, 2024 were $-0.429B, a 40.66% increase year-over-year.
  • Teva Pharmaceutical Industries other operating income or expenses for the twelve months ending September 30, 2024 were $-0.646B, a 34.08% decline year-over-year.
  • Teva Pharmaceutical Industries annual other operating income or expenses for 2023 were $-0.994B, a 49.67% decline from 2022.
  • Teva Pharmaceutical Industries annual other operating income or expenses for 2022 were $-1.975B, a 219.06% increase from 2021.
  • Teva Pharmaceutical Industries annual other operating income or expenses for 2021 were $-0.619B, a 2995% increase from 2020.
Teva Pharmaceutical Industries Annual Other Operating Income or Expenses
(Millions of US $)
2023 $-994
2022 $-1,975
2021 $-619
2020 $-20
2019 $-1,102
2018 $1,499
2017 $699
2016 $-130
2015 $-465
2014 $111
2013 $-1,524
2012 $-715
2011 $-471
2010 $-410
2009 $-638
Teva Pharmaceutical Industries Quarterly Other Operating Income or Expenses
(Millions of US $)
2024-09-30 $-429
2024-06-30 $-81
2024-03-31 $-107
2023-12-31 $-29
2023-09-30 $-305
2023-06-30 $-429
2023-03-31 $-231
2022-12-31 $-15
2022-09-30 $-193
2022-06-30 $-695
2022-03-31 $-1,072
2021-12-31 $-579
2021-09-30 $22
2021-06-30 $37
2021-03-31 $-99
2020-12-31 $-41
2020-09-30 $-13
2020-06-30 $-4
2020-03-31 $38
2019-12-31 $40
2019-09-30 $-454
2019-06-30 $-637
2019-03-31 $-51
2018-12-31 $-74
2018-09-30 $16
2018-06-30 $76
2018-03-31 $1,481
2017-12-31 $923
2017-09-30 $24
2017-06-30 $-300
2017-03-31 $52
2016-12-31 $544
2016-09-30 $-533
2016-06-30 $-166
2016-03-31 $25
2015-12-31 $66
2015-09-30 $80
2015-06-30 $-384
2015-03-31 $-227
2014-12-31 $44
2014-09-30 $122
2014-06-30 $-26
2014-03-31 $-29
2013-12-31 $-15
2013-09-30 $-47
2013-06-30 $-1,435
2013-03-31 $-27
2012-12-31 $620
2012-09-30 $-1,131
2012-06-30 $-55
2012-03-31 $-149
2011-12-31 $-119
2011-09-30 $-51
2011-06-30 $-272
2011-03-31 $-29
2010-12-31 $-332
2010-09-30 $-53
2010-06-30 $9
2010-03-31 $-34
2009-12-31
2009-09-30
2009-06-30
2009-03-31
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $19.044B $15.846B
Teva Pharmaceutical Industries Limited is a global pharmaceutical company that develops, manufactures, and markets both branded and generic drugs, as well as active pharmaceutical ingredients in North America, Europe, Latin America, India, and Israel. Teva's generic product portfolio includes tablets, capsules, liquids, ointments, creams, liquids, injectables, and inhalants. The company's branded products include Copaxone, Austedo, respiratory products like ProAir and Qvar and Ajovy. Teva operates through three segments, North America, Europe and International Markets, each of which includes generics, specialty and over-the-counter products. Teva acquired Allergan's generics business Actavis Generics. The company also acquired Allergan's Anda Inc. Teva acquired Auspex Pharmaceuticals and Barr. Teva has strengthened its position in Europe through its acquisition of Germany's second largest generics producer, ratiopharm.
Stock Name Country Market Cap PE Ratio
Dr Reddy's Laboratories (RDY) India $11.978B 22.92
BridgeBio Pharma (BBIO) United States $4.260B 0.00
Bausch Health Cos (BHC) Canada $3.012B 2.18
Amphastar Pharmaceuticals (AMPH) United States $2.097B 12.61
Supernus Pharmaceuticals (SUPN) United States $1.962B 26.71
Taysha Gene Therapies (TSHA) United States $0.434B 30.29
Personalis (PSNL) United States $0.261B 0.00
Assembly Biosciences (ASMB) United States $0.098B 0.00
Sol-Gel Technologies (SLGL) Israel $0.012B 0.00
Evoke Pharma (EVOK) United States $0.007B 0.00
Teligent (TLGT) United States $0.000B 0.00